Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review.
García-Beloso N, Altabás-González I, Samartín-Ucha M, Gayoso-Rey M, De Castro-Parga ML, Salgado-Barreira Á, Cibeira-Badia A, Piñeiro-Corrales MG, González-Vilas D, Pego-Reigosa JM, Martínez-López de Castro N. García-Beloso N, et al. Br J Clin Pharmacol. 2022 Feb;88(4):1529-1550. doi: 10.1111/bcp.15101. Epub 2021 Nov 2. Br J Clin Pharmacol. 2022. PMID: 34622969 Free article. Review.
Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments.
Martínez-López-de-Castro N, Samartín-Ucha M, Paradela-Carreiro A, Pérez-Landeiro A, Inaraja-Bobo MT, Álvarez-Payero M, Castro-Núñez I, García-Beloso N, Robles-Torres D, López-López A, González-Costas S, Leboreiro-Enríquez B, Otero-Millán L, Yaiza Romero-Ventosa E, Casanova-Martínez C, Lorenzo-Lorenzo K, Regueira-Arcay AM, Vázquez-López C, Martínez-Reglero C, Piñeiro-Corrales G. Martínez-López-de-Castro N, et al. Among authors: garcia beloso n. J Clin Pharm Ther. 2021 Jun;46(3):724-730. doi: 10.1111/jcpt.13337. Epub 2020 Dec 23. J Clin Pharm Ther. 2021. PMID: 33368439
Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice.
Gayoso-Rey M, Díaz-Trastoy O, Romero-Ventosa EY, García-Beloso N, González-Freire L, Lorenzo-Lorenzo K, Mantiñán-Gil B, Palmeiro-Carballeira R, Bravo-Amaro M, López-Gil-Otero MDM, Martínez-Reglero C, Crespo-Diz C, Fernández-Catalina P, Piñeiro Corrales G. Gayoso-Rey M, et al. Among authors: garcia beloso n. Clin Ther. 2021 Apr;43(4):e111-e121. doi: 10.1016/j.clinthera.2021.02.002. Epub 2021 Mar 9. Clin Ther. 2021. PMID: 33712271
Regorafenib and trifluridine/tipiracil in real clinical practice.
García-Beloso N, Romero-Ventosa EY, Gayoso-Rey M, López-López A, Robles-Torres D, de Castro NM, Piñeiro-Corrales G. García-Beloso N, et al. J Cancer Res Ther. 2022 Dec;18(Supplement):S367-S373. doi: 10.4103/jcrt.JCRT_1316_20. J Cancer Res Ther. 2022. PMID: 36510990 Free article.